Priority Date: 15.03.13 (US 201361791706P)

SALT FORMS OF (S)-QUINUCLIDIN-3-YL (2-(2-(4-FLUOROPHENYL)THIAZOL-4-YL)PROPAN-2-YL)CARBAMATE

  • Application ID: EP14718854
  • Status: EXAMINATION IN PROGRESS

Applicant

Technology company logo small
Technology Company

Attorney

no operation time available
Headquarter in London and 5 offices
active in Legal Services and Matchmaking and Trading

Specialization

This EP application has the IPC combination A61 (MEDICAL OR VETERINARY SCIENCE; HYGIENE) and C07 (ORGANIC CHEMISTRY). Mathys & Squire LLP is specialized in the combination A61 and C07. We found, that TransMIT GmbH, Kailuweit & Uhlemann, Lederer Keller Patentanwälte Partnerschaft mbB, Vossius & Partner Patentanwälte Rechtsanwälte mbB, df-mp Dörries Frank-Molnia & Pohlman, Patentanwälte Rechtsanwälte PartG mbB and 229 others are specialized in all of these IPC classes as well. For a similar patent, they might be a good choice.

Timeline

  • 15.03.2013 - Priority Date (US 201361791706P)
  • 25.09.2014 - Publication A1 (WO2014152215)
  • 20.01.2016 - Publication A1 (EP2970250)